Literature DB >> 10840606

[Transmission of HBV, HCV and HIV by infectious medical personnel--presentation of an overview].

H M Hasselhorn1, F Hofmann.   

Abstract

This report analyzes 46 cases of personnel-to-patient transmissions of hepatitis B (HB), hepatitis C (HC) and HIV in health care settings. Similar circumstances were found for transmission of HB (40 cases, 404 infected patients), HC (4 cases, 224 infected patients) and HIV (2 cases, 7 infected patients). Cases with the highest number of transmissions (one anesthesiologist with 217 HC transmissions, and one EEG technologist with 75 HB transmissions) were attributed to poor infection control practices. As long as infected health care workers (HCW) adhere to general infection control measures, a risk for transmission to patients exists only from infected surgeons who perform 'exposure-prone invasive procedures'. Whether changes in duties of infected HCW are necessary should be decided on an individual basis. Often, the infected personnel were assumed to have acquired the disease occupationally. Medical practices and devices bearing a risk of infection should constantly be reviewed with regard to risk for patients and personnel.

Entities:  

Mesh:

Year:  2000        PMID: 10840606     DOI: 10.1007/s001040051070

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  3 in total

Review 1.  Hepatitis B and the infected health care worker: public safety at what cost?

Authors:  Mamatha Bhat; Peter Ghali; Marc Deschenes; Philip Wong
Journal:  Can J Gastroenterol       Date:  2012-05       Impact factor: 3.522

2.  [HCV, HBV and HIV infections: risk for surgeon and staff. Results and consequences of routine screening in emergency patients].

Authors:  K Dresing; C Pouwels; S Bonsack; M Oellerich; H Schwörer; A Uy; K M Stürmer
Journal:  Chirurg       Date:  2003-11       Impact factor: 0.955

3.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.